It has been suggested that although HDL-c and ApoA-I are considered atheroprotective, in prooxidant and inflammatory conditions such as diabetes and obesity, chemical modifications such as oxidation and nitration can result in dysfunctionality and abnormality, promoting increased cardiovascular risk. This evidence concerns the gene APOA1 and obesity disorder.